Molecular Pain

Molecular Pain is a fully open-access specialist journal of pain research, founded in 2005 by BioMed Central and published by SAGE Publications since 2016. It filled the gap of a dedicated forum for the molecular aspects of pain research, and is an electronic-only journal, appearing as one volume a year with articles published online first.《分子疼痛》(Molecular Pain)是一份完全开放获取的疼痛研究专科期刊,二〇〇五年由生物医学中心(BioMed Central)创办,二〇一六年起转由赛吉出版(SAGE Publications)出版。该刊补上了疼痛研究领域缺少分子层面专门论坛的空白,是纯电子刊,每年一卷、文章在线优先发表。

Scope

Molecular Pain takes pain research at the cellular, subcellular and molecular levels as its brief, its official scope stressing the integration of pain research with molecular biology, genomics, proteomics, modern electrophysiology and neurobiology. Its principal subject areas include:Molecular Pain 的取稿立场是「在细胞、亚细胞与分子层面研究疼痛」,官方范围说明强调把疼痛研究与分子生物学、基因组学、蛋白质组学、现代电生理学与神经生物学相结合。收文范围覆盖的主要方向包括:

History

Editors

The journal is run by two co-editors-in-chief, supported by five deputy editors, a managing editor and an editorial board of about fifty, with an advisory board including such figures of pain research as Borsook, Burnstock and Porreca. Official peer-review policy expects the review period not to exceed three weeks, and no acceptance rate is published.本刊实行双主编制,配五名副编辑、一名管理编辑与约五十人的编辑委员会,另设由多布克、伯恩斯托克与波雷卡等疼痛研究名家组成的顾问编委会。官方同行评审政策预期评审周期不超过三周,出版方未公布录用比例。[6]